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Abstract
Objective	:	To	study	the	prevalence,	awareness	and	control	of	hypertension	in	Chennai	representing	Urban	
South	India.
Methods	:	The Chennai	Urban	Rural	Epidemiology	Study	(CURES)	is	one	of	the	largest	epidemiological	
studies	on	diabetes	carried	out	 in	 India,	where	26,001	 individuals	aged	≥	20	years	were	screened	using	
systematic	random	sampling	method.	Every	tenth	subject	recruited	in	Phase	1	of	CURES	was	requested	to	
participate	in	Phase	3	of	CURES	and	the	response	rate	was	2,350/26,001	or	90.4%.	An	oral	glucose	tolerance	
test	was	performed	in	all	individuals	except	self-reported	diabetic	subjects.	Anthropometric	measurements	
and	lipid	estimations	were	done	in	all	subjects.	Hypertension	was	diagnosed	in	all	subjects	who	were	on	
drug	treatment	for	hypertension	or	if	the	blood	pressure	≥	140/90	mmHg.
Results	:	Hypertension	was	present	in	20%	[men:23.2%	vs.	women:17.1%,	p<0.001]	of	the	study	population.	
Isolated	systolic	hypertension	(Systolic	BP	≥	140	and	Diastolic	BP<90	mmHg)	was	present	in	6.6%	while	
isolated	diastolic	hypertension	 (DBP	≥	 90	and	SBP<140	mmHg)	was	present	 in	4.2%	of	 the	population.	
Among	the	elderly	population	(aged	≥	60	years),	25.2%	had	isolated	systolic	hypertension.	Age,	body	mass	
index,	smoking,	serum	cholesterol	and	triglycerides	were	found	to	be	strongly	associated	with	hypertension.	
Among	the	total	hypertensive	subjects,	only	32.8%	were	aware	of	their	blood	pressure,	of	these,	70.8%	were	
under	treatment	and	45.9%	had	their	blood	pressure	under	control.
Conclusion	 :	Hypertension	was	present	 in	one-fifth	of	 this	urban	south	 Indian	population	and	 isolated	
systolic	hypertension	was	more	common	among	elderly	population.	Majority	of	hypertensive	subjects	still	
remain	undetected	and	the	control	of	hypertension	is	also	inadequate.	This	calls	for	urgent	prevention	and	
control	measures	for	hypertension.	©
been	 identified	as	one	of	 the	 leading	 risk	 factors	 for	
mortality,	and	is	ranked	third	as	a	cause	of	disability-
adjusted	 life-years.3	 Existing	data	 suggests	 that	 the	
prevalence	of	hypertension	has	remained	stable	or	has	
decreased	in	economically	developed	countries	during	
the	past	decade,	while	it	has	increased	in	developing	
countries.4	However,	the	increase	in	the	prevalence	rates	
of	hypertension	needs	 to	be	quantified	 so	as	 to	plan	
for	effective	prevention	strategies	which	are	urgently	
needed	in	developing	countries.	
Given	 the	 rising	 prevalence	 of	 hypertension	 in	
developing	 countries	 undergoing	 epidemiological	
transition	 like	 India,	 increased	awareness,	 treatment,	
and	 control	 of	 high	 blood	 pressure	 are	 critical	 to	
the	 reduction	 of	 cardiovascular	 disease	 risk	 and	
prevention	of	 the	 associated	burden	of	 illness.	 This	
study	was	undertaken	with	the	objective	to	gather	both	
epidemiological	data	and	data	on	awareness	and	control	
of	 hypertension	 in	Chennai	which	 represents	urban	
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INTRODUCTION
Hypertension	 is	 becoming	 an	 important	 public	 health	problem	worldwide.	A	recent	report	on	the	
global	 burden	of	 hypertension	 indicates	 that	 nearly	
1	 billion	 adults	 (more	 than	 a	quarter	 of	 the	world’s	
population)	 had	 hypertension	 in	 2000,	 and	 this	 is	
predicted	to	increase	to	1.56	billion	by	2025.1	Subjects	
with	hypertension	are	known	to	have	a	two-fold	higher	
risk	of	developing	coronary	artery	disease	(CAD),	four	
times	higher	risk	of	congestive	heart	failure	and	seven	
times	higher	risk	of	cerebrovascular	disease	and	stroke	
compared	to	normotensive	subjects.2	Hypertension	has	
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south	India.	Such	studies	are	a	crucial	step	in	the	design	
of	hypertension	prevention	and	control	programs	at	a	
national	level.
Study Design
The	Chennai	Urban	Rural	 Epidemiology	 Study	
(CURES)	 is	 a	 large	 cross-sectional	 study	done	 on	 a	
representative	population	of	Chennai	(formerly	Madras)	
city	 in	 southern	 India	with	 a	population	of	 about	 5	
million	people.	The	detailed	study	design	of	CURES	is	
described	elsewhere5	and	the	sampling	frame	is	shown	
in	our	website	http://www.drmohansdiabetes.com/
mdrf/CURES.pdf.	
Phase 1	of	CURES	was	conducted	in	the	field,	and	
involved	a	door-to-door	survey	of	26,001	 individuals	
≥20	years	of	age	drawn	randomly	from	46	of	 the	155	
corporation	wards	in	Chennai.	A	detailed	questionnaire	
was	 administered	 to	 all	 study	 subjects	 to	 collect	
information	 regarding	demographic,	 socio-economic,	
behavioural	 and	 health	 status.	A	 fasting	 capillary	
blood	sugar,	blood	pressure	and	basic	anthropometric	
measures	were	done	in	all	individuals.
Phase 2	of	CURES	deals	with	studies	of	the	prevalence	
of	microvascular	and	macrovascular	complications	of	
diabetes.	Phases	1	and	2	are	not	discussed	 further	 in	
this	article.
In	Phase 3	of	CURES,	every	tenth	subject	recruited	in	
Phase	1	(n=2600)	was	invited	to	our	centre	for	detailed	
anthropometric	measurements	and	biochemical	tests.	Of	
these,	2350	participated	in	the	present	study	(response	
rate:	90.4%).		This	sample	is	thus	representative	of	the	
Chennai	population.
All	 the	 study	 subjects	underwent	 an	oral	 glucose	
tolerance	test	(OGTT)	using	75gm	glucose	load,	except	
self-reported	diabetic	subjects,	for	whom	fasting	venous	
plasma	glucose	was	measured.	The	fasting	blood	sample	
was	taken,	after	ensuring	8	hours	of	overnight	fasting,	
for	 estimation	 of	 plasma	 glucose	 and	 serum	 lipids	
using	a	Hitachi	912	Autoanalyser	 (Roche	Diagnostics	
GmbH,	Mannheim,	Germany)	utilizing	kits	supplied	by	
Boehringer	Mannheim	(Mannheim,	Germany).	Glycated	
hemoglobin	 (HbA1c)	was	measured	 by	 the	High	
Pressure	Liquid	Chromatography	(HPLC)	method	using	
the	Variant	machine	 (BIORAD,	Hercules,	California).	
Anthropometric	measurements	 including	weight,	
height,	waist	 and	hip	measurements	were	 obtained	
using	standardized	techniques	as	given	below.
Height	was	measured	with	a	tape	to	the	nearest	cm.	
Subjects	were	requested	to	stand	upright	without	shoes	
with	their	back	against	the	wall,	heels	together	and	eyes	
directed	forward.
Weight	was	measured	with	 a	 traditional	 spring	
balance that	was	 kept	 on	 a	 firm	horizontal	 surface.	
Subjects	were	asked	to	wear	light	clothing	and	weight	
was	recorded	to	the	nearest	0.5	kg.
Body mass index (BMI)	was	 calculated	using	 the	
formula:	weight	(Kg)/height (m)2.
Waist circumference:	Waist	was	measured	using	
a	non-stretchable	measuring	 tape.	The	 subjects	were	
asked	 to	 stand	erect	 in	 a	 relaxed	position	with	both	
feet	 together	 on	 a	 flat	 surface;	 one	 layer	 of	 clothing	
was	accepted.	Waist	girth	was	measured	as	the	smallest	
horizontal	girth	between	the	costal	margins	and	the	iliac	
crests	at	minimal	respiration.
Blood pressure	was	recorded	in	the	sitting	position	in	
the	right	arm	to	the	nearest	2mmHg	using	the	mercury	
sphygmomanometer	(Diamond	Deluxe	BP	apparatus,	
Pune,	India).	Two	readings	were	taken	5	minutes	apart	
and	mean	of	two	was	taken	as	the	blood	pressure.
The	 institutional	 ethical	 committee	 approval	was	
obtained	and	informed	consent	was	obtained	from	all	
study	subjects.
Definitions
Hypertension: Hypertension	was	diagnosed	based	
on	drug	 treatment	 for	 hypertension	 or	 if	 the	 blood	
pressure	was	 greater	 than	 140/90	mmHg	 –	 Joint	
National	Committee	7	(JNC	VII)	Criteria.6                                           
Diabetes: Diagnosis	of	diabetes	was	based	on	WHO	
Consulting	group	criteria,	i.e.	2	hour	post	load	plasma	
glucose	[2hr	PG]	≥200	mg/dl	(≥11.1	mmol/l).	Impaired	
glucose	 tolerance	 (IGT)	was	diagnosed	 if	 the	2hr	PG	
was	≥140	mg/dl	(≥7.8	mmol/l)	and	<200	mg/dl	(<11.1	
mmol/l)	and	normal	glucose	tolerance	(NGT)	if	2hr	PG	
was	<140	mg/dl	(<7.8	mmol/l).7 
Dyslipidemia: National	 Cholesterol	 Education	
Programme	(NCEP)	guidelines8	were	used	for	definition	
of	dyslipidemia.
Hypercholesterolemia	 :	 Serum	 cholesterol	 levels	
≥200	mg/dl	 (≥5.2	mmol/l)	 or	 drug	 treatment	 for	
hypercholesterolemia.
Hypertriglyceridemia	 :	 Serum	 triglyceride	 levels	
were	≥150	mg/dl	(≥1.7	mmol/l)	or	drug	treatment	for	
hypertriglyceridemia.	
Low HDL cholesterol	:	HDL	cholesterol	levels	were	
<40	mg/dl	(<1.04	mmol/l)	for	men	and	<50	mg/dl	(<1.3	
mmol/l)	for	women.
Obesity :	Generalized	obesity	was	defined	using	the	
new	WHO	Asia	Pacific	guidelines9	i.e.	BMI	≥25	kg/m2 
and	abdominal	obesity	as	waist	circumference	≥90	cm	
for	men	and	≥80	cm	for	women.
Statsitical Analysis
Statistical	 analyses	were	 performed	 using	 SPSS	
windows	version	 10.0	 software	 (SPSS	 Inc.,	Chicago,	
Illinois).	 Student’s	 t	 tests	were	used	 for	 continuous	
variable	and	chi	square	test	for	proportions.	Multiple	
logistic	regression	analysis	was	done	using	hypertension	
as	the	dependent	variable	and	the	various	risk	factors	
as	independent	variables.	P	value	<0.05	was	considered	
significant.
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RESULTS
Distribution of systolic and diastolic blood pressure:
The	mean	 systolic	 BP	 for	men	 and	women	were	
121	and	117	mmHg	respectively.	The	25th	percentiles	
of	systolic	BP	for	men	and	women	were	110	and	105	
mmHg,	 50th	 percentiles,	 120	 and	 115	mmHg,	 75th 
percentiles,	130	and	120	mmHg	and	the	90th	percentiles	
141	and	140	mmHg	respectively.	The	mean	diastolic	BP	
for	men	and	women	were	76	and	73	mmHg	respectively.	
The	25th	percentiles	of	diastolic	BP	for	men	and	women	
were	70	and	65	mmHg,	the	50th	percentiles	were	75	and	
72	mmHg,	75th	percentiles	were	81	and	80	mmHg	and	the	
90th	percentiles	were	90	and	88	mmHg	respectively.	
Prevalence of hypertension:
The	overall	prevalence	of	hypertension	in	the	study	
population	was	20%	 (469/2350)	 and	 this	was	higher	
in	men	 than	 in	women	 (men:	 23.2%,	women:	 17.1%,	
p<0.001).	The	prevalence	of	self-reported	hypertension	
was	 6.6%	 (154/2350)	 (men:	 7.9%,	 women:	 5.3%,	
p<0.007).	 Figure	 1 shows	 the	genderwise	prevalence	
of	 hypertension	 across	 different	 age	 groups.	 The	
prevalence	of	hypertension	steadily	increased	with	age	
in	both	sexes	and	was	3.8%	in	men	and	3.1%	in	women	
at	the	age	group	of	20-29	years,	which	increased	rapidly	
and	reached	a	prevalence	of	50.8%	in	men	and	51%	in	
women	at	the	age	of	60	years	and	above	[men:	trend	chi	
square	120.1,	p<0.001;	women:	trend	chi	square	166.9,	
p<0.001).
Table	 1	 shows	 the	 general	 characteristics	 of	 the	
study	 subjects.	Hypertensive	 subjects	were	 older,	
had	 significantly	 higher	 body	mass	 index,	waist	
circumference,	waist-to-hip	 ratio,	 serum	cholesterol,	
serum	triglycerides,	LDL	cholesterol	and	HbA1C	levels	
compared	to	normotensive	subjects.
Age-specific	 estimates	 of	 the	 distribution	 of	 BP	
according	to	the	classification	system	recommended	by	
the	Joint	National	Committee	on	Detection,	Evaluation	
and	 Treatment	 of	High	 Blood	 Pressure	 (JNC-VII)	
are	presented	 in	Figure	 2.	The	overall	prevalence	of	
prehypertension,	 stage	 1	 hypertension	 and	 stage	 2	
hypertension	were	36.1%,	15.1%	and	4.9%	respectively.	
The	prevalence	of	prehypertension,	stage	1	and	stage	2	
hypertension	increased	with	increasing	age.	(Age:	20-
29	years,	prehypertension	33.1%,	stage	1	hypertension	
3.2%	 and	 stage	 2	 hypertension	 0.2%;	 30-39	 years,	
35.4%,	11.7%	and	2.3%;	40-49	years:	40.5%,	18.3%	and	
6.4%;	50-59	years:	 39.4%,	25.8%	and	8.4%;	60+	years:	
30.6%,	34.2%	and	16.7%).	Trend	chi	square,	p	value	 -	
prehypertension:	0.787,	p=0.375;	stage	1	hypertension:	
163.4,	p<0.001;	 stage	2	hypertension:	 107.2,	p<0.001).	
Men	had	higher	prevalence	of	hypertension	compared	
to	women	(Prehypertension:	men	37.9%,	women	34.5%,	
p=0.09;	stage	1	hypertension:	men	17.6%,	women	12.9%,	
p<0.05;	stage	2	hypertension:	men	5.6%,	women	4.2%,	
p=0.15).
The	 study	 population	 were	 categorized	 as	
normotensives	 (SBP<140	mm	Hg	 and	DBP<90	mm	
Hg),	treated	hypertensives	(hypertensives	under	anti-
Table 1 : Clinical and demographic characteristics of the 
study subjects
Variable	 Normotensives	 Hypertensives	 P	value
	 (n=1881)	 (n=469)
Age	(yrs)	 37	±	12	 49	±	13	 <0.001
Male	n	(%)	 842	(44.8)	 254	(54.2)	 <0.001
BMI	(kg/m2)	 22.5	±	3.9	 24.3	±	3.7		 <0.001
Waist	circumference		 82.1	±	11.2	 88.7	±	10.6	 <0.001
(cm)
Hip	circumference	 93.1	±	8.9	 95.9	±	8.5	 <0.001
(cm)
Waist-to-hip	ratio	 0.88	±	0.09	 0.93	±	0.09	 <0.001
Total	cholesterol	 176	±	38	 193	±	38	 <0.001
(mg/dl)
Serum	triglycerides	 117	±	77	 157	±	100	 <0.001
(mg/dl)
HDL	cholesterol	 43	±	10	 43	±	10	 0.982
(mg/dl)
LDL	cholesterol	 110	±	33	 119	±	34	 <0.001
(mg/dl)
HbA1C	 5.9	±	1.3	 6.7	±	1.8	 <0.001
Fig. 1 : Prevalence of hypertension by sex and age among the Chennai 
population
Fig. 2 : Percentage distribution of blood pressure levels of Chennai 
population based on JNC VII criteria
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hypertensive	drugs)	and	untreated	hypertensives.	The	
mean	BP	among	the	general	population	was	SBP:	119	±	
18	mmHg,	DBP:	74	±	11	mmHg;	among	normotensives	
it	was	SBP:	113	±	12	mmHg,	DBP:	71	±	9	mmHg,	among	
treated	hypertensives	it	was	SBP:	137	±	22	mmHg,	DBP:	
83	±	11	mmHg	and	among	untreated	hypertensives	it	
was	SBP:	143	±	28	mmHg,	DBP:	87	±	13	mmHg.
Prevalence of isolated systolic and isolated diastolic 
hypertension:
Based	on	the	JNC-VII	classification,	isolated	systolic	
hypertension	 (SBP	≥140	 and	DBP	<90	mm	Hg)	was	
present	in	6.6%	of	the	subjects	(6.9%	of	men	and	6.2%	
of	women)	while	isolated	diastolic	hypertension	(DBP	
≥90	and	SBP	<140mm	Hg)	was	present	in	4.2%	of	the	
subjects	 (5.4%	of	men	and	3.1%	of	women)	 (Fig.	 3).	
As	 age	 increased,	 the	prevalence	of	 isolated	 systolic	
hypertension	increased	at	a	slower	pace	until	the	age	
of	50	years,	after	which	(i.e.,	age	≥50	years),	it	increased	
dramatically	 yielding	 a	 prevalence	 of	 11.9%	 (men:	
10.9%,	women:	13.1%)	at	the	age	group	of	50-59	years	
and	25.2%	(men:	21.4%,	women:	30.2%)	at	the	age	of	60	
years	and	above.	Women	had	a	higher	prevalence	of	
isolated	systolic	blood	pressure	after	the	age	of	40	years	
compared	to	men.	The	prevalence	of	isolated	diastolic	
hypertension	also	increased	but	at	a	slower	pace	until	
the	age	of	50	years	but	decreased	thereafter.	Women	had	
a	lower	prevalence	of	isolated	diastolic	blood	pressure	
compared	to	men	across	all	age	groups.
Risk factors for hypertension
Table	 2 shows	 a	multivariate	 logistic	 regression	
analyses	 on	 the	 risk	 factors	 for	 hypertension.	As	
independent	variables,	gender	(men	versus	women),	age	
(15-year	increments),	obesity	(WHO	Asian	guidelines),	
abdominal	obesity	(WHO	Asian	guidelines),	smoking	
(yes	versus	no),	serum	cholesterol	(≥200	mg/dl	versus	
<200	mg/dl)	 and	 triglycerides	 [≥150	mg/dl	 versus	
<150	mg/dl]	were	included,	with	hypertension	as	the	
dependent	variable.	The	odds	 ratios	 for	 age	 ranged	
between	3.52	(95%	CI:	2.61	–	4.74)	and	13.45	(95%	CI:	
8.70	–	20.78),	which	shows	the	strong	association	of	age	
with	hypertension.	Compared	to	those	below	35	years,	
subjects	between	35-49	years	were	 at	 3	 times	higher	
risk	of	hypertension;	 subjects	between	50-64	years	at	
>8	times	higher	risk	while	those	above	65	years	were	
at	>13	times	higher	risk	of	hypertension.	The	odds	ratio	
Table 2 : Multivariate regression analysis for association of various risk factors with prevalence of hypertension
Variable	 n	 	 Prevalence	 	 	 Multivariate	logistic	regression
	 	 %	 95%	CI	 P		(X2)	 OR	 95%	CI	 P
Gender	 	 	 	 	 	 	
	 Men	 1096	 23.2	 20.7	–	25.7	 <0.001	 1	 	 <0.001
	 Women	 1254	 17.2	 15.1	–	19.3	 	 0.69	 0.56	–	0.84	
Age	(yrs)	 	 	 	 	 	 	
	 20	–	34	 941	 7.0	 5.4	–	8.6	 <0.001	 1	 	
	 35	–	49	 877	 21.0	 18.3	–	23.7	 	 3.52	 2.61	–	4.74	 <0.001
	 50	–	64	 411	 38.4	 33.7	–	43.1	 	 8.26	 6	–	11.37	 <0.001
	 65	+	 121	 50.4	 41.5	–	59.3	 	 13.45	 8.7	–	20.78	 <0.001
Body	mass	index	(kg/	m2)	 	 	 	 	 	 	
	 Normal	(<	23)	 1215	 14.4	 12.4	–	16.4	 <0.001	 1	 	
	 Overweight	(23–24.9)	 472	 22.5	 18.7	–	26.3	 	 1.72	 1.32	–	2.26	 <0.001
	 Obese	(≥25)	 657	 28.5	 25.0	–	32.0	 	 2.37	 1.87	–	2.99	 <0.001
Abdominal	obesity	 	 	 	 	 	 	
	 No	 1165	 14.0	 12.0	–	16.0	 <0.001	 1	 	
	 Yes	[WC:	≥90	(m);	≥80	(f)]	 1126	 26.1	 23.5	–	28.7	 	 2.17	 1.76	–	2.69	 <0.001
Smoking	 	 	 	 	 	 	
	 No	 1910	 18.7	 17.0	–	20.4	 0.001	 1	 	
	 Yes	 437	 25.6	 21.5	–	29.7	 	 1.50	 1.18	–	1.91	 0.001
Serum	cholesterol	(mg/dl)	 	 	 	 	 	 	
	 Normal	 1726	 16.6	 14.8	–	18.4	 <0.001	 1	 	
	 Hypercholesterolemia	 621	 29.3	 25.7	–	32.9	 	 2.08	 1.68	–	2.58	 <0.001
Triglycerides	(mg/dl)	 	 	 	 	 	 	 	
	 Normal	 1753	 16.6	 14.9	–	18.3	 <0.001	 1	 	
	 Hypertriglyceridemia	 589	 30.2	 26.5	–	33.9	 	 2.18	 1.75	–	2.7	 <0.001
OR	–	Odds	ratio;	CI	–	Confidence	Interval;	X2	–	Chi	square
Fig. 3 : Prevalence of isolated systolic and diastolic hypertension by 
different age group among the Chennai population
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for	hypertension	in	those	with	obesity	ranged	from	1.72	
(95%	CI:	1.32	–	2.26)	to	2.37	(95%	CI:	1.87	–	2.99).	The	
multivariate	regression	analysis	also	revealed	abdominal	
obesity	(OR:	2.17,	95%	CI:	1.76	–	2.69,	p<0.001),	smoking	
(OR:	1.50,	95%	CI:	1.18	–	1.91,	p<0.001),	serum	cholesterol	
[OR:	 2.08,	 95%	CI:	 1.68	 –	 2.58,	 p<0.001)	 and	 serum	
triglycerides	(OR:	2.18,	95%	CI:	1.75	–	2.70,	p<0.001)	to	
be	strongly	associated	with	hypertension.
Prevalence of metabolic abnormalities
The	prevalence	of	metabolic	disorders	like	diabetes,	
obesity,	 hypercholesterolemia,	 hypertriglyceridemia,	
abdominal	and	general	obesity	were	higher	in	subjects	
with	hypertension	compared	to	normotensive	subjects	
[hypertensive	subjects	versus	normotensives	-	diabetes:	
31.8%	 vs	 11.6%;	 IGT:	 17.9%	 vs	 8.8%;	 hyperchole-
sterolemia:	38.8%	vs	23.4%;	hypertriglyceridemia:	38%	
vs	 22%;	 abdominal	 obesity:	 64.3%	vs	 45.4%;	general	
obesity:	40%	vs	25.2%].
Awareness and control of hypertension
Of	 the	 total	hypertensive	 subjects,	 469	/	2350	 (i.e.	
20%),	 the	 proportion	 of	 subjects	with	 self-reported	
hypertension	was	154	(representing	32.8%	of	the	total	
hypertensive	subjects).	Of	the	154	known	hypertensive	
subjects,	 109	 (70.8%)	 were	 under	 treatment	 for	
hypertension.	However,	of	these	109	individuals,	only	50	
(45.9%)	had	blood	pressure	under	control	(i.e.	<140/90),	
which	represents	15.4%	of	the	total	hypertensive	group	
(Fig.	 4).	 Treatment	 and	 control	were	more	 common	
among	men	 than	among	women.	 75.9%	of	men	and	
64.2%	of	women	were	taking	prescribed	medication	to	
lower	their	BP,	of	which,	only	47%	of	men	and	44.2%	of	
women	achieved	BP	control.
A	 similar	 analysis	was	done	 among	 the	diabetic	
population.	Of	 the	 total	 diabetic	 subjects	 (n	=	 365),	
149	(40.8%)	had	hypertension.	The	difference	between	
prevalence	 of	 hypertension	 among	diabetic	 (40.8%,	
149/365)	and	non	diabetic	subjects	[16.1%,	320/1985]	
reached	statistical	significance	(p<0.001).	56.4%	of	the	
diabetic	population	had	undiagnosed	hypertension.	Of	
the	known	diabetic	hypertensive	subjects,	69.2%	were	on	
treatment	for	hypertension	and	of	these	51.1%	had	their	
blood	pressure	under	control.	Thus	overall,	only	22.1%	
of	 the	diabetic	hypertensive	 subjects	had	 their	blood	
pressure	under	control.	Among	the	diabetic	population,	
treatment	of	hypertension	was	more	common	among	
men	(men:	75.7%	vs	women:	60.7%)	while	the	control	
of	blood	pressure	was	more	common	among	women	
(men:	46.4%	vs	women:	58.8%).
DISCUSSION
The	 overall	 prevalence	 of	 hypertension	 in	 this	
representative	 urban	population	 of	Chennai	which	
is	 representative	of	urban	 south	 India	 is	 20%	 -	 thus	
one	fifth	of	the	adult	population	≥20	years	of	age	now	
have	 hypertension.	 Various	 studies	 in	 developing	
countries	estimated	a	prevalence	rate	of	hypertension	
among	urban	population	ranging	from	1.24%	in	1949	
to	36.4%	 in	2003.10	The	difference	 in	prevalence	 rates	
could	be	due	 to	different	cut	points	used	 in	defining	
the	level	of	hypertension	and	also	differing	age	groups	
constituting	 the	 study	population.	The	prevalence	of	
hypertension	 in	 Jaipur	 representing	 an	urban	north	
Indian	population	aged	20	years	and	above	was	30%	
in	men	and	33%	in	women	using	JNC	V	criteria.11	The	
prevalence	of	hypertension	in	the	urban	population	of	
West	Bengal,	representing	eastern	India	was	reported	
to	be	24.9%,	based	on	JNC	VII	criteria.12	The	prevalence	
of	 hypertension	 among	 the	 urban	 population	 of	
Trivandrum	city	in	Kerala	in	the	south	western	India	
was	 reported	 to	be	33.5%	 in	 the	age	groups	between	
45	 and	 64	 years.13	 The	prevalence	 rates	 reported	 in	
the	present	 study	are	 therefore	 comparatively	 lower	
that	 that	 reported	 in	other	 studies.	This	 is	 similar	 to	
the	findings	of	the	World	Health	Organization	(WHO)	
and	Indian	Council	of	Medical	Research	(ICMR)	non-
communicable	disease	(NCD)	risk	factor	surveillance	
where	 the	 prevalence	 of	 hypertension	 among	 the	
industrial	population	was	26%	in	all	ten	centres	in	India14 
and	25.4%	in	Chennai.15
Isolated	systolic	blood	pressure	was	present	in	25.2%	
(21.4%	of	men	and	30.2%	of	women)	among	the	elderly	
study	population	 (aged	60	years	and	above).	Among	
the	general	population,	 isolated	 systolic	 and	 isolated	
diastolic	blood	pressure	was	present	in	6.6%	and	4.2%	of	
the	study	population	respectively.	Women	had	a	higher	
prevalence	of	isolated	systolic	blood	pressure	and	lower	
prevalence	of	diastolic	pressure	compared	to	men.	The	
SHEP	(Systolic	Hypertension	in	the	Elderly	Program)	
study	 showed	 that	 this	 type	of	high	blood	pressure	
is	more	 common	 in	older	 adults,	 especially	 in	older	
women.16	Moreover,	after	menopause,	there	is	a	sharp	
increase	in	the	prevalence	of	hypertension	in	women	to	
levels	that	equal	or	surpasses	that	of	men;	this	suggests	
that	 ovarian	hormones	participate	 in	 the	protection	
afforded	to	premenopausal	women.17	These	may	be	the	
reasons	for	higher	prevalence	of	isolated	hypertension	
among	older	women	in	the	present	study.
The	present	study	had	shown	a	large	proportion	of	
sample	population	in	the	prehypertensive	group.	Even	
at	 the	youngest	 age	group	 studied	 (20-29	years),	 the	
proportion	of	subjects	with	prehypertension	was	33%,	
which	 is	very	high.	 In	 recognizing	 ‘prehypertension’	Fig. 4 : Prevalence of hypertension and control among the Chennai population
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as	 a	 clinical	 condition,	 JNC	VII	pointed	out	 that	BP	
related	mortality	 is	 linear	 and	 that	higher	BP	 levels	
within	what	was	earlier	called	‘high	normal’	or	‘normal’	
range	 is	 associated	with	 increasing	morbidity	 and	
mortality.18	In	the	US	population	≥20	years	of	age,	36%	
(62	million)	had	high-normal	blood	pressure	or	greater	
(systolic	/	diastolic	blood	pressure	≥130	/	≥85	mm	Hg).	
Of	 the	adult	population	of	 the	NHANES	 in	US,	61%	
has	prehypertension	or	hypertension	using	 the	 JNC	
VII	definition.6	The	Trial	of	Preventing	Hypertension	
(TROPHY)	study19	on	individuals	with	high	normal	BP	
suggests	clearly	that	the	risk	of	cardiovascular	disease	
begins	 to	rise	before	 the	diagnosis	of	hypertension	 is	
evident.	Ours	is	the	first	population	based	study	to	our	
knowledge	to	report	on	prevalence	of	prehypertension	
in	India	i.e.	after	the	JNC	VII	report	was	published.
Various	 risk	 factors	 have	 been	 associated	with	
hypertension	in	epidemiological	surveys.	In	the	CUPS	
study,	reported	by	us	earlier	from	Chennai,	age,	body	
mass,	waist	 hip	 ratio	 and	 glucose	 intolerance	 had	
a	 significant	 association	with	 hypertension.20	 The	
significant	determinants	of	hypertension	in	the	urban	
population	of	Jaipur	were	age,	smoking	and	body	mass	
index.11	 In	 another	 study	 conducted	 in	urban	North	
Indians,	age,	higher	body	mass	index,	central	obesity	and	
higher	socioeconomic	status	(SES)	were	independently	
and	strongly	associated	with	hypertension	in	both	sexes,	
while	higher	dietary	fat,	salt	intake	and	lower	physical	
activity	were	weakly	but	significantly	associated	with	
higher	prevalence	and	 level	of	hypertension.21	These	
findings	were	consistent	with	the	present	study	findings	
which	 revealed	 that	 age,	body	mass	 index,	 smoking,	
serum	 cholesterol	 and	 triglycerides	 to	 be	 strongly	
associated	with	hypertension.
The	‘rule	of	halves’	for	hypertension	states	that:	‘half	
the	people	with	high	blood	pressure	are	not	known,	
half	of	those	known	are	not	treated	and	half	of	those	
treated	are	not	 controlled’.	 If	 this	 rule	 is	 valid,	 then	
only	one	in	eight	of	the	hypertensive	population	would	
be	receiving	optimal	treatment.	An	attempt	was	made	
to	assess	 the	applicability	of	 the	rule	of	halves	 in	 the	
urban	 south	 Indian	population	 in	 this	 study.	Among	
the	hypertensive	 subjects,	 32.8%	were	 aware	 of	 the	
condition,	of	whom	70.8%	of	them	were	on	treatment	
and	of	these	only	45.9%	had	their	blood	pressure	under	
control	i.e.	(<140/90),	which	represents	15%	of	the	total	
hypertensive	group.	Among	 the	diabetic	population	
with	hypertension,	43.6%	were	aware	of	the	condition	
of	whom	69.2%	had	undergone	treatment	for	it	and	of	
these	51.1%	were	under	control,	which	represents	22%	
of	the	total	diabetic	hypertensive	group.	Thus	the	‘rule	
of	halves’	 is	 still	valid	 in	urban	south	 India	as	 far	as	
hypertension	 is	 concerned.	The	present	 study	 shows	
a	 general	 improvement	 in	detection,	 treatment	 and	
control	 of	 hypertension	 compared	 to	 earlier	 studies	
in	Chennai.22	However,	 85%	of	hypertensive	 subjects	
and	78%	of	diabetic	hypertensive	 subjects	 still	 have	
not	achieved	adequate	control,	which	underscores	the	
urgent	need	to	develop	national	strategies	for	prevention	
and	treatment	of	hypertension	in	India.
Although	effective	 therapy	has	been	available	 for	
more	than	50	years,6	most	persons	with	hypertension	
do	 not	 have	 their	 blood	 pressure	 under	 control.	
The	US	Department	 of	Health	 and	Human	Services	
National	health	objectives	for	201023	include	reducing	
the	proportion	of	adults	with	high	blood	pressure	 to	
16%	 (US	baseline:	 28%;	CURES:	 20%),	 increasing	 the	
proportion	of	adults	with	hypertension	who	are	taking	
action	to	control	it	to	95%	(US	baseline:	82%;	CURES:	
71%),	 and	 increasing	 the	proportion	 of	 adults	with	
controlled	BP	to	50%	(US	baseline:	18%;	CURES:	15%).	
The	results	of	the	present	study	shows	that	compared	to	
the	US	population,	there	is	long	way	to	go	to	accomplish	
the	goal	 of	 optimal	 control	 among	 the	 south	 Indian	
population.	Undoubtedly	a	similar	situation	exists	 in	
other	parts	of	the	country	as	well.	It	took	atleast	30	to	
40	years	of	 sustained	effort	 to	 substantially	 improve	
hypertension	detection	and	control	in	western	countries,	
and	the	rates	are	still	far	from	optimal.24	It	is	therefore	
obvious	 that	considerable	effort	 is	needed	to	prevent	
or	 reduce	 the	 increasingly	 large	 burden	 of	 disease	
related	to	increasing	rates	of	hypertension	in	countries	
in	epidemiological	transition,	such	as	India.
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